Added to YB: 2017-03-24
Pitch date: 2017-03-24
KPTI:US [bullish]
Karyopharm Therapeutics Inc.
-94.45%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States.
Market Cap
$201.0M
Pitch Price
$145.35
Price Target
N/A
Dividend
N/A
EV/EBITDA
-5.04
P/E
-0.50
EV/Sales
3.03
Sector
Biotechnology
Category
N/A
Show full summary:
KARYOPHARM THERAPEUTICS INC COM KPTI:US
A summary for this pitch has not been created yet.
Read full article (0 min)